Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Enhertu
Enhertu
AstraZeneca to unveil key data for cancer drugs at ASCO
Pharmaforum
Fri, 05/15/20 - 10:41 am
AstraZeneca
ASCO 2020
Tagrisso
lung cancer
Enhertu
breast cancer
gastric cancer
colorectal cancer
AstraZeneca, Daiichi Sankyo get FDA breakthrough therapy status for gastric cancer drug
Pharmaceutical Business Review
Mon, 05/11/20 - 10:27 am
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
gastric cancer
breakthrough therapy
Astra, Daiichi's Enhertu shows early promise in HER2 lung cancer
Fierce Biotech
Wed, 03/25/20 - 10:49 am
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
HER2-positive non-small cell lung cancer
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
AZ, Daiichi’s new cancer drug Enhertu gets off to the races with quick U.S. launch
Fierce Pharma
Mon, 02/10/20 - 11:42 pm
AstraZeneca
Daiichi Sankyo
clinical trials
FDA
Enhertu
cancer
breast cancer
Antibody-drug conjugates on the march
Pharmaforum
Thu, 01/30/20 - 10:41 am
antibody-drug conjugate
AstraZeneca
Daiichi Sankyo
Enhertu
3 Blockbuster Cancer Drug Launches to Watch in 2020
Motley Fool
Thu, 01/2/20 - 11:57 pm
FDA
drug approvals
cancer
drug launches
AstraZeneca
Enhertu
Padcev
Seattle Genetics
BeiGene
Brukinsa
FDA hastily approves Daiichi Sankyo/AZ’s cancer drug, weeks after US filing
Pharmaforum
Mon, 12/23/19 - 11:46 pm
FDA
AstraZeneca
Daiichi Sankyo
advanced breast cancer
Enhertu
Pages
« first
‹ previous
1
2
3